Table 3.
Progression free survival | Overall survival | |||||
---|---|---|---|---|---|---|
Univariate (p value) | Multivariate (p value) | Hazard ratio (95%CI) | Univariate (p value) | Multivariate (p value) | Hazard ratio (95%CI) | |
Age: ≥ 70 vs < 70 | 0.195 | 0.638 | ||||
Gender: male vs female | 0.607 | 0.774 | ||||
ECOG PS: 0 vs 1–2 | 0.435 | 0.866 | ||||
Lesion number: single vs multiple | 0.008 | 0.010 | 0.46 (0.26–0.83) | 0.053 | 0.112 | 0.43 (0.15–1.22) |
Histology: CRC vs others | 0.496 | 0.935 | ||||
Previous chemotherapy: yes vs no | 0.378 | 0.927 | ||||
Posterior chemotherapy: yes vs no | 0.088 | 0.126 | 1.60 (0.88–2.93) | 0.035 | 0.078 | 2.72 (0.90–8.27) |
ECOG Eastern Cooperative Oncology Group, PS performance status, CRC colorectal cancer, CI confidence interval